About
We are a united group of scientists, logistics experts and clinicians inspired by the staggering molecular complexity of the natural world, driven to unlock novel therapeutic applications
Our Common Goal
We strive to unlock key molecular targets applying innovation and scientific rigour to genetics, processes and products.
Our Facility
Newly constructed 20,000 ft2 plant, designed and constructed to meet EU-GMP standards, located in Victoria, BC.
Our Emblem
A fusion of the Mobius strip with the Gordian Knot, our emblem symbolizes enigmatic phenomena, problem solving, and outside-the-box thinking.
Capabilities, Certifications, and Affiliations
Health Canada Licensed for Cannabis
Standard Cultivation
Standard Processing
Medical Sales
2.0 product Sales
Psilocybin
Confirmation of readiness, Health Canada license pending
GACP certification circa October 2024
Royal College of Physicians and Surgeons of Canada
University of British Columbia
Clinical Directorship: Dr. A. I. Moldoveanu
Dr. Moldoveanu received his Bachelor of Science degree with Honours in Human Biology, minoring in Anthropology, from the University of Toronto. He then finished his Master of Science thesis in Immunology at the University of Toronto, before pursuing his MD degree at Albany Medical College in Upstate New York. He received specialty training in Internal Medicine at McMaster University and finished fellowship training in Endocrinology and Metabolism at the University of Western Ontario, ultimately board certifying in both specialties.
Dr. Moldoveanu is Clinical Assistant Professor at the University of British Columbia, and Head of the Division of Endocrinology and Metabolism in Victoria, British Columbia, where he is currently engaged in full time practice and clinical research. He is a Fellow of the Royal College of Physicians and Surgeons of Canada, and Owner and Director of Unite Biotechnical and Unite Biomedical, corporations dedicated to phytocannabinoid and endocannabinoid research and development, as well as the study and advancement of indolealkylamine/5hydroxytryptamine mimetic-containing compounds.